Revolutionizing Cardiac Surgery Outcomes

Dr. David Skinner, MD, PhD, MBA, FMHC, is a visionary leader and serial entrepreneur whose innovative spirit and strategic acumen have reshaped the medical industry. As the CEO and President of BioMatrix, LLC, he spearheads a company dedicated to advancing healthcare solutions, leveraging his extensive expertise and a proven track record of building and scaling transformative enterprises.

With a robust academic foundation, Dr. Skinner earned his MD and PhD, equipping him with deep insights into medical science and research, complemented by an MBA that honed his business leadership skills.

Dr. Skinner's entrepreneurial journey is marked by the creation and successful exit of multiple medical companies. A serial founder, he has a knack for identifying unmet needs in healthcare and building organizations from the ground up to address them. One of his standout achievements was growing a medical company from a carefully selected team of five to a thriving enterprise with 156 employees across nine locations. Every aspect of this organization—from its operational framework to its culture—was designed and developed under his direct leadership. Through strategic partnerships and private equity investment, Dr. Skinner orchestrated a successful exit, cementing his reputation as a builder of high-value, scalable businesses.

At BioMatrix, LLC, Dr. Skinner continues to drive innovation, fostering a culture of excellence and collaboration. His leadership is defined by a relentless pursuit of impactful solutions, blending clinical expertise, business savvy, and a passion for improving lives. Under his guidance, BioMatrix is poised to redefine standards in healthcare, building on his legacy of transforming ideas into industry-leading enterprises.

Chief Growth Officer, Melissa Mitchell brings over 21 years of business development, sales and marketing experience to the team. As the Director of Business Development at Ephibian, a global software development company, she has been building key relationships across multiple domains for the last 21 years. Including Department of Defense, members of the Fortune 500, start-up's, R&D and universities. Clients include, University of Arizona, The Critical Path Institute, Cardiac Partners, DoD, MEDSReM, etc. Melissa served MenoLabs, now Dr. Reddy's as a product development lead for MenoLife, an app in the FemTech space. Working closely with the executive team, technology team, researchers and end users to help guide architecture, design and feature sets, improving engagement and conversions. Prior Melissa worked at Jack Morton Worldwide, a multinational brand experience agency, serving clients such as, Dell, 3M, AMD and Motorola in experiential marketing campaigns successfully driving year-over-year revenue growth as a strategic partner and trusted advisor.

Chief Science Officer, John P. Konhilas, Ph.D. is Professor of Physiology who, over the past 30 years, built integrative and translational research projects focused on therapeutic development for cardiac health outcomes. Dr. Konhilas founded several biotechnology companies based on this scientific research, including, most recently, Menolabs, LLC, in 2019, with the direct mission to deliver microbiome-based strategies to improve health-related outcomes in menopausal women. Due to the success of this mission, Menolabs was acquired in 2022. Dr. Konhilas holds 11 patents with a recent IND approval for clinical trial research. Doctor Konhilas is lead researcher on a number of revolutionary new DuPont Probiotic patents including Bifidobacterium animalis ssp. Lactis 420 and has published a large body of work related to menopause and cardiovascular disease, women's health when aging, the gut microbiome, and the effect of probiotics in reducing the symptoms of menopause.